Sign Up to like & get
recommendations!
0
Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30845
Abstract: Recombinant human lymphotoxin‐α derivative (rhLTα‐Da) is a lymphotoxin‐α derivative that is missing 27 N‐terminal amino acid residues. Previous studies indicated a benefit from the addition of rhLTα‐Da to cisplatin‐based treatment in patients with metastatic esophageal…
read more here.
Keywords:
recombinant human;
lymphotoxin;
metastatic esophageal;
patients metastatic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Advances in Therapy"
DOI: 10.1007/s12325-020-01394-y
Abstract: Introduction Currently available second-line (2L) therapies for advanced/metastatic esophageal squamous cell carcinoma (adv/met ESCC) include the taxanes paclitaxel and docetaxel. In clinical trials, such therapies have provided only modest improvements in survival. Few studies have…
read more here.
Keywords:
advanced metastatic;
metastatic esophageal;
patients receiving;
adv met ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010928
Abstract: Abstract Whether the survival outcome of patients with non-metastatic esophageal squamous cell carcinoma (NM-ESCC) receiving definitive concurrent chemoradiotherapy (CCRT) is better with intensity-modulated radiotherapy (IMRT) or with 3-dimensional conformal radiotherapy (3DCRT) has been debated in…
read more here.
Keywords:
esophageal;
metastatic esophageal;
patients non;
radiotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000020064
Abstract: Supplemental Digital Content is available in the text
read more here.
Keywords:
distantly metastatic;
stage survival;
esophageal cancer;
relationship stage ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of cutaneous pathology"
DOI: 10.1111/cup.14185
Abstract: Breakthrough targeted therapies have produced significant improvements in survival for cancer patients, but have a propensity to cause cutaneous immune-related adverse events (irAEs). Psoriasiform irAEs, representing about 4% of dermatologic toxicities associated with immune checkpoint…
read more here.
Keywords:
ici therapy;
immune related;
psoriasiform;
pustular psoriasiform ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Pharmacology"
DOI: 10.1159/000527697
Abstract: Background: Metastatic esophageal carcinoma (EC) has a poor prognosis and only limited treatment options. While immune checkpoint inhibitors (ICIs) have improved the treatment of a broad spectrum of cancers, patients with EC mostly fail to…
read more here.
Keywords:
metastatic esophageal;
combination;
checkpoint;
esophageal carcinoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "World Journal of Gastrointestinal Oncology"
DOI: 10.4251/wjgo.v14.i2.511
Abstract: BACKGROUND Chemotherapy has long been shown to confer a survival benefit in patients with metastatic esophageal cancer. However, not all patients with metastatic disease receive chemotherapy. AIM To evaluate a large cancer database of metastatic…
read more here.
Keywords:
cancer;
esophageal cancer;
receiving chemotherapy;
chemotherapy ... See more keywords